This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

New research reveals insomnia's deep links to cardiovascular health, urging us to treat it as a core medical issue, not a ...

DOES trying to book a GP appointment feel like a wild goose chase? Even when you finally manage to secure a slot, it often ...

It is reasonable to view stimulus control as an effective insomnia treatment, particularly for sleep initiation problems. It is practical to see stimulus control as an effective treatment for insomnia ...

Insomnia is the most common sleep disorder. In the U.S., 10-15% of the population suffers at least 3 nights a week or more and for 3 months or longer with difficulties getting to sleep and/or staying ...

A majority of people with insomnia respond to behavioral and nonpharmacologic methods. When compared with pharmacologic methods, they are at least as efficacious and have the advantage of continued ...

TOKYO--(BUSINESS WIRE)--SUSMED, Inc. (TOKYO:4263) announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (the ”MHLW”) of SUSMED Med CBT-i® App for Insomnia (the ...

With no long-term treatments for insomnia, researches have begun exploring the use of cognitive behavioral therapy in combination with medication to treat the disease. With no long-term treatments for ...

Insomnia affects nearly a quarter of children. Insomnia can cause difficulties with falling asleep, frequent awakenings during the night, and waking up too early in the morning. As a result of ...

The National Institute for Health and Care Excellence (NICE) has recommended daridorexant (QUVIVIQ, Idorsia) as a new treatment option for long-term insomnia but underscored the importance of keeping ...